EDAP TMS SA Announces Financial Results Release
EDAP TMS SA (Nasdaq: EDAP), a pioneer in the field of robotic energy-based therapies, is set to disclose its financial outcomes for the third quarter soon. The announcement is anticipated on a Thursday in early November, a crucial date for stakeholders.
Conference Call Details
The company's leadership team, including Ryan Rhodes (CEO), Ken Mobeck (CFO), and François Dietsch (Chief Accounting Officer), will lead a conference call and webcast to discuss these results. Following the financial report, they will address any questions from analysts and investors, providing a comprehensive view of the company’s performance and strategic direction.
When and How to Join
The conference call is scheduled for 8:30 AM EDT, ideal for both domestic and international participants. Interested parties can dial in using the following numbers:
- Domestic: 1-800-445-7795
- International: 1-785-424-1699
- Passcode: EDAP
Innovative Solutions from EDAP TMS
EDAP TMS is recognized for its groundbreaking contributions to the therapeutic ultrasound market. The company specializes in minimally invasive medical devices designed for various conditions, utilizing advanced ultrasound technology. Their flagship product, the Focal One®, is engineered to address prostate tissue ablation efficiently.
Full Spectrum of Prostate Cancer Solutions
Comprehensively addressing prostate cancer treatment, EDAP TMS has also introduced the ExactVu™ Micro-Ultrasound device. This innovation positions the company uniquely in the market, offering a complete solution from diagnostics through to focal treatment.
Advanced Treatment Technologies
Beyond prostate cancer, EDAP TMS crafts and distributes a variety of medical technologies, including the Sonolith® i-move lithotripter. This system facilitates the treatment of urinary tract stones through extra-corporeal shockwave lithotripsy (ESWL), showcasing the company's diverse product offering and commitment to medical advancements.
Learn More About EDAP TMS SA
For a deeper understanding of EDAP TMS and its extensive range of services and products, you can visit the company’s official website at www.edap-tms.com. Here you can find additional resources and updates regarding their latest innovations.
Communication with the Company
EDAP TMS encourages open communication with stakeholders and the public. For any inquiries, you may contact:
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
Phone: +33 4 72 15 31 50
Email: bconfort@edap-tms.com
For Investor Relations:
John Fraunces
LifeSci Advisors, LLC
Phone: (917) 355-2395
Email: jfraunces@lifesciadvisors.com
Frequently Asked Questions
What is the date for EDAP TMS's Q3 2024 financial results announcement?
EDAP TMS will announce its financial results on a Thursday in early November 2024.
Who will lead the conference call for EDAP TMS?
The conference call will be conducted by Ryan Rhodes (CEO), Ken Mobeck (CFO), and François Dietsch (Chief Accounting Officer).
What time will the conference call take place?
The conference call is scheduled for 8:30 AM EDT.
How can I participate in the conference call?
You can join by dialing the domestic number 1-800-445-7795 or the international number 1-785-424-1699, using the passcode EDAP.
Where can I find more information about EDAP TMS's products?
You can visit www.edap-tms.com for comprehensive information about their innovative medical devices and technologies.